cro.directory
← Compare landing

Oncodesign Services vs Synexa Life Sciences

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryOncodesign ServicesSynexa Life Sciences
SummaryContract research organization specializing in drug discovery and preclinical services for oncology, inflammation, and infectious diseases since 1995.Biomarker and bioanalytical CRO offering custom assay development, validation and clinical sample analysis by LC-MS/MS, MSD, flow cytometry and Olink proteomics. Labs in Manchester, Turku and Cape Town support work from discovery through regulatory submission.
Services
  • Discovery Research
  • Target Identification & Validation
  • High-Throughput Screening
  • Medicinal Chemistry
  • Computational & In-Silico Drug Discovery
  • Preclinical In Vitro Studies
  • In Vitro Pharmacology
  • In Vitro ADME / DMPK
  • Safety Pharmacology
  • Genetic Toxicology
  • Preclinical In Vivo Studies
  • In Vivo Efficacy Models
  • In Vivo PK / PD Studies
  • GLP Toxicology
  • Carcinogenicity Studies
  • DART (Reproductive & Developmental Toxicology)
  • Specialized & Large-Animal Models
  • Bioanalysis
  • LC-MS Bioanalysis (Small Molecule)
  • Ligand-Binding Bioanalysis (Large Molecule)
  • Immunogenicity Assays (ADA / NAb)
  • Biomarker Assays
  • Flow Cytometry Services
  • Clinical Imaging Core Lab
  • Regulatory Affairs
  • Analytical Method Development & Validation
  • ICH Stability Studies
  • Translational Research
  • Virology Services
  • Immunology & Inflammation Services
  • Oncology Specialty Services
  • Bioanalysis
  • LC-MS Bioanalysis (Small Molecule)
  • Ligand-Binding Bioanalysis (Large Molecule)
  • Immunogenicity Assays (ADA / NAb)
  • Biomarker Assays
  • Flow Cytometry Services
  • Translational Research
  • Immunology & Inflammation Services
  • Genomics & Sequencing Services
  • Proteomics Services
Modalities
  • Small Molecule
  • Biologics (Other)
  • Antibody-Drug Conjugate (ADC)
  • Radiopharmaceutical
  • Small Molecule
  • Biologics (Other)
  • Antibody-Drug Conjugate (ADC)
  • Cell Therapy
  • Vaccine
  • Radiopharmaceutical
Indications
  • Oncology
  • Immunology
  • Metabolic
  • Infectious Disease
  • Rare Disease
  • Respiratory
  • Dermatology
  • Gastroenterology
  • Nephrology
  • Oncology
  • Immunology
  • Metabolic
Phases
  • Discovery
  • Preclinical (General)
  • Preclinical (IND-Enabling)
Data not yet provided.
Sourcing models
  • Full-Service Outsourcing (FSO)
  • Functional Service Provider (FSP)
Locations
  • Headquarters, Dijon, Bourgogne-Franche-Comté, France
  • Headquarters
  • Manchester, Manchester, United Kingdom
  • Turku, Turku, Finland
  • Cape Town, Cape Town, South Africa
CertificationsData not yet provided.Data not yet provided.

Find similar companies

Oncodesign Services alternatives · Synexa Life Sciences alternatives

Markdown mirror: /compare/oncodesign-services/synexagroup.md